ReadyPrep

Adult dose

In adults over 18 years of age, take the medication divided or undivided as follows: 1) Divided dosing method: The day before the colonoscopy, take the prepared solution of 1L (500mL solution * 2 preparations) over 1 hour (250mL per cup every 15 minutes), and then drink an additional 500mL of water. The following morning, take another prepared solution of 1L (500mL solution * 2 preparations) over 1 hour and drink an additional 500mL of water.

This medication can rarely cause generalized tonic-clonic seizures even in patients without a history of seizures, so caution is needed in cases of electrolyte abnormalities. This medication should not be used in patients with intestinal obstruction, gastrointestinal blockage, perforation, toxic colitis, or toxic megacolon, and should be administered cautiously in patients with severe ulcerative colitis. This medication contains the artificial sweetener aspartame, which should not be administered to patients with phenylketonuria. It should not be used in patients with hypersensitivity to this medication or with specific conditions such as gastrointestinal obstruction, perforation, dehydration, severe heart failure, active solid tumors, or bowel motility disorders. Elderly patients, those who are frail, patients with severely impaired kidney function, and those with vomiting reflex disorders should use this medication cautiously, and should discontinue use and consult a physician if severe abdominal pain or distension occurs. Various adverse reactions have been reported with this medication, including hunger, hypophosphatemia, hypokalemia, sleep disturbances, dizziness, headache, abdominal pain, nausea, vomiting, fatigue, tremors, etc., and serious side effects such as gastrointestinal bleeding or acute pulmonary edema may occur, particularly in elderly patients. Before administering this medication, the patient's bowel movement status should be verified, and during administration, bowel activities should be monitored to ensure they remain normal. Bowel activity typically begins within about 1 hour after administration, and abdominal distension may occur before this, so if severe symptoms arise, the administration rate should be adjusted, or temporarily halted. If symptoms of fluid or electrolyte imbalance appear, blood tests should be performed to check the condition and appropriate treatment provided, and electrocardiograms may be necessary in patients at high risk of arrhythmias. This medication may induce diarrhea, so adequate hydration before and after administration is necessary. This medication may cause ulcerations of the bowel mucosa, so it should be avoided in conjunction with irritant laxatives, and patients with inflammatory bowel disease should be cautious. Patients should finish eating at least 1 hour before administration and should avoid solid food. The effects on driving or operating machinery are not known. This medication may interfere with the absorption of some oral medications, so there is a possibility of interactions with drugs taken within 1 hour before administration. Pregnant or breastfeeding women should only use this medication when the benefits outweigh the risks, as its safety has not been established. It should not be used in children as safety and efficacy have not been confirmed, and elderly patients are at higher sensitivity and should be monitored closely. Overdosage may result in dehydration and severe electrolyte disturbances, so symptoms should be closely monitored and appropriate treatment provided. No other ingredients or flavorings should be added before use, and the solution should be taken immediately after preparation, with any unused solution discarded within 24 hours. This medication should be kept out of the reach of children, and the prepared solution should be stored refrigerated with the lid closed, as transferring to another container may adversely affect quality.

Serious side effects

Hives, swelling, anaphylactic reactions, upper gastrointestinal bleeding due to damage to the gastric mucosa (Mallory-Weiss tear), esophageal perforation, cardiac arrest, acute pulmonary edema, tachycardia, palpitations, hypertension, arrhythmia, atrial fibrillation, peripheral edema, cardiac arrest, acute pulmonary edema, syncope, dehydration, anaphylactic reactions, hives, lip swelling, tongue swelling, facial swelling, difficulty breathing, chest tightness, throat tension, seizures.

Mild side effects

• Hunger
• hypophosphatemia
• hypokalemia
• sleep disturbances
• dizziness
• headache
• upper abdominal pain
• abdominal pain
• nausea
• abdominal distension

This medication should be stored in a tightly closed container to protect it from air and moisture, at room temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain its efficacy for a longer period.

Appearance

1) Product A: A white or off-white powder with a lemon scent, packed in an aluminum foil pouch. 2) Product B: A white crystal or crystalline powder with no odor and a sour taste, packed in an aluminum foil pouch.

Package unit

Product A: 56.0818g/packet * 4, Product B: 5.3g/packet * 4